Albireo Pharma Investor Relations Material
Latest events
Q3 2022
Albireo Pharma
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Albireo Pharma Inc
Access all reports
Albireo Pharma Inc. is a biopharmaceutical company specializing in the development and commercialization of treatments for rare liver diseases, particularly in pediatric and adult populations. The company’s focus is on conditions such as progressive familial intrahepatic cholestasis (PFIC), biliary atresia, and Alagille syndrome.
Latest articles
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
)
500 Years of Craft, One Family Legacy: Beretta Holding's Global Expansion
How Beretta Holding managed to transform from a 16th-century gun barrel producer into a global industrial group while preserving 500 years of legacy.
27 Jun 2025
)
Shuntaro Furukawa: The Sixth President of Nintendo
Shuntaro Furukawa, Nintendo's sixth president, went from a childhood fan to leading the company through global expansion and the launch of Switch 2.
23 Jun 2025
Ticker symbol
ALBO
Country
🇺🇸 United States